We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Redesigned MabThera for Treatment of ALS

News   May 26, 2017 | Original Story from Ben-Gurion University of the Negev

 
Academic Redesigns FDA-Approved MabThera to Treat ALS

Dr. Rachel Lichtenstein, Ben-Gurion University of the Negev

 
 
 

RELATED ARTICLES

Researchers Observe Drug Target Assembling in Real-time

News

Over one-third of all FDA-approved drugs act on a specific family of proteins called G-protein coupled receptors (GPCRs). Researchers now show when and how different parts of a GPCR interacts with its G protein signaling partners.

READ MORE

In the Bonobo Dating Scene, Mothers Go the Extra Mile to Aid Reproductive Success

News

Researchers have found that while both bonobo and chimpanzee mothers will advocate for their sons in male-on-male conflicts, bonobo moms go the extra mile to aid their sons’ copulation efforts.

READ MORE

Inhaled Steroids No Better Than Placebo for Many Asthma Sufferers

News

A study of nearly 300 patients with mild persistent asthma found that inhaled steroids—long considered the gold standard for asthma treatment—were no more effective than placebo in nearly 75 % of the study patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE